AngioSoma, Inc. (SOAN) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Houston, TX, United States. El CEO actual es Alex K. Blankenship.
SOAN tiene fecha de IPO 2022-01-31, cotiza en el Other OTC.
AngioSoma, Inc., a wellness company, engages in the development and commercialization of dietary supplements to the medical, wellness, and adult-use markets. The company was founded in 2016 and is based in Houston, Texas.
